Unlocking hope for mitochondrial disorders with INTEGRA Biosciences’ electronic pipette Post author: Post published:October 2, 2023 Post category:uncategorized INTEGRA Biosciences’ VOYAGER adjustable tip spacing pipette to support their research on mitochondrial diseases. You Might Also Like Weill Cornell Medicine receives $3.4 million NIH grant to study type 1 diabetes development September 11, 2025 Study links child behavior stress and lower self-regulation in parents October 22, 2025 Study sheds new light on the variety of cellular causes of rheumatoid arthritis November 9, 2023
Weill Cornell Medicine receives $3.4 million NIH grant to study type 1 diabetes development September 11, 2025